Böddrich A, Griesser J, Horn D, Kaufmann D, Krone W, Nürnberg P
Institut für Medizinische Genetik, Universitätsklinikum Charité, Berlin, Germany.
Biochem Biophys Res Commun. 1995 Sep 25;214(3):895-904. doi: 10.1006/bbrc.1995.2371.
We screened a total of 87 unrelated patients with neurofibromatosis type 1 (NF1) for mutations in exons 11, 12a, and 12b of the NF1 gene using temperature gradient gel electrophoresis (TGGE). A novel mutation (1998insCCTCT) was found in exon 12b. The 5-bp duplication comprising nucleotides 1994 to 1998 is predicted to lead to a truncated protein product lacking three quarters of its C-terminal sequence including the entire GTPase-activating protein-(GAP)-related domain. This mutation is associated with a reduction by 50% of the detectable amount of neurofibromin found in this patient. Despite the reduced level of neurofibromin cellular GAP activity was normal, which suggests that defects in other functions of the neurofibromin molecule may be important in the pathogenesis of NF1.
我们使用温度梯度凝胶电泳(TGGE)对总共87名散发性1型神经纤维瘤病(NF1)患者的NF1基因第11、12a和12b外显子进行了突变筛查。在第12b外显子中发现了一个新的突变(1998insCCTCT)。由核苷酸1994至1998组成的5个碱基对的重复预计会导致产生一种截短的蛋白质产物,该产物缺少其C末端序列的四分之三,包括整个GTP酶激活蛋白(GAP)相关结构域。该突变与该患者中可检测到的神经纤维瘤蛋白量减少50%有关。尽管神经纤维瘤蛋白水平降低,但细胞GAP活性正常,这表明神经纤维瘤蛋白分子其他功能的缺陷可能在NF1的发病机制中起重要作用。